These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2936363)

  • 21. [Chagas' disease. Entomological surveillance activities developed in an area of the State of São Paulo, Brazil].
    da Rocha e Silva EO; Maluf J; Corrêa Rde R
    Rev Saude Publica; 1970 Dec; 4(2):129-45. PubMed ID: 4993630
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chagas disease in the Americas: current situation and perspectives].
    Dias JC; Silveira AC
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():5-13. PubMed ID: 16482805
    [No Abstract]   [Full Text] [Related]  

  • 23. Lessons from a national survey of Chagas disease transmission risk in Colombia.
    Guhl F; Restrepo M; Angulo VM; Antunes CM; Campbell-Lendrum D; Davies CR
    Trends Parasitol; 2005 Jun; 21(6):259-62. PubMed ID: 15922243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
    Marin-Neto JA; Rassi A; Morillo CA; Avezum A; Connolly SJ; Sosa-Estani S; Rosas F; Yusuf S;
    Am Heart J; 2008 Jul; 156(1):37-43. PubMed ID: 18585495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four TDR diseases can be "eliminated". 3. Chagas success in Brazil and Colombia.
    TDR News; 1996 Mar; (49):3-4. PubMed ID: 12294419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chagas disease: the epidemiological and control aspects].
    Silveira AC; Vinhaes M
    Rev Soc Bras Med Trop; 1998; 31 Suppl 2():15-60. PubMed ID: 10444969
    [No Abstract]   [Full Text] [Related]  

  • 27. [I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy].
    Andrade JP; Marin-Neto JA; Paola AA; Vilas-Boas F; Oliveira GM; Bacal F; Bocchi EA; Almeida DR; Fragata Filho AA; Moreira Mda C; Xavier SS; Oliveira Junior WA; Dias JC;
    Arq Bras Cardiol; 2011; 97(2 Suppl 3):1-48. PubMed ID: 21952638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Socio-cultural and economic aspects of the spread and control of human Chagas disease].
    Dias JC
    Ann Soc Belg Med Trop; 1985; 65 Suppl 1():119-26. PubMed ID: 3931577
    [No Abstract]   [Full Text] [Related]  

  • 29. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [American human trypanosomiasis 90 years after its discovery by Carlos Chagas. I. Epidemiology and control].
    Pays JF
    Med Trop (Mars); 1998; 58(4):391-402. PubMed ID: 10399701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of Chagas disease interventions in latin america and the Caribbean: Markov models.
    Wilson LS; Strosberg AM; Barrio K
    Am J Trop Med Hyg; 2005 Nov; 73(5):901-10. PubMed ID: 16282301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medico-social importance of Chagas' disease in Brazil and its control].
    Silveira AC; Sakamoto T
    Rev Bras Malariol Doencas Trop; 1983; 35():127-34. PubMed ID: 6438708
    [No Abstract]   [Full Text] [Related]  

  • 33. The ecology of Chagas disease in Chile.
    Schofield CJ; Apt W; Miles MA
    Ecol Dis; 1982; 1(2-3):117-29. PubMed ID: 6821391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistance and susceptibility to insecticides of Triatoma infestans, vector of Chagas' disease].
    Corréa Rde R; Ramalho GR; Zaia L; Cunha JT; Cavalcante A; Rosário F
    Rev Bras Malariol Doencas Trop; 1971; 23(1):125-34. PubMed ID: 5005716
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guidelines for Chagas disease. 2006. Part I. Introduction and epidemiology].
    Rev Chilena Infectol; 2008 Jun; 25(3):189-93. PubMed ID: 18580996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of Chagas disease control.
    Schofield CJ; Jannin J; Salvatella R
    Trends Parasitol; 2006 Dec; 22(12):583-8. PubMed ID: 17049308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Status of Chagas disease in the Americas].
    Bol Oficina Sanit Panam; 1984 Aug; 97(2):159-65. PubMed ID: 6238606
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serological certification of the interruption of the vectorial transmission of Chagas disease in Chile].
    Lorca M; García A; Bahamonde MI; Fritz A; Tassara R
    Rev Med Chil; 2001 Mar; 129(3):264-9. PubMed ID: 11372293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic Chagas : infection and epileptic syndromes].
    Medrado-Faria MA; Marques-Assis L; da Silva GR; Camargo ME
    Rev Inst Med Trop Sao Paulo; 1976; 18(3):173-81. PubMed ID: 821132
    [No Abstract]   [Full Text] [Related]  

  • 40. New global effort to eliminate Chagas disease.
    Wkly Epidemiol Rec; 2007 Jul; 82(28-29):259-60. PubMed ID: 17642099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.